Osteoarthritis of the knee
Conditions
Interventions
PRP 1.5 mL to which the same amount of local anesthesia is added is administered intra-articularly twice every 4 weeks from the blood collection
Sponsors
Teikyo University School Orthopedics
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Standing load , It is diagnosed as osteoarthritis by 4way knee joint radiography 2) It is an adult whose age is 20 years old or more at the time of consent acquisition 3) You have obtained written informed consent from the subject himself / herself 4) You have agreed that you are not taking internal medicine to control osteoarthritis pain within 2weeks of initial administration (excluding acetaminophen)
Exclusion criteria
Exclusion criteria: 1) Patients undergoing intra-articular injection of steroids and hyaluronic acid formulations within 2 weeks of initial administration 2) Patients with inflammatory joint disease (such as rheumatoid arthritis disease) 3) Patients who can not comply with the instructions of a doctor 4) Pregnant or lactating women, women who may be pregnant, are not willing to contrace during clinical research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main evaluation items will be tracked and evaluated for the duration of pain control effect by VAS and evaluation by patient standing scores for 6 months every month from PRP administration. At the same time, image evaluation with MRI is performed regularly as to whether there is a fault as a secondary evaluation item | — |
Secondary
| Measure | Time frame |
|---|---|
| Regularly evaluate the presence or absence of a fault as a secondary evaluation item and image evaluation by MRI | — |
Countries
Japan
Contacts
Public ContactNishihara Nobuhiro
Teikyo University School of Medicine affiliated hospital Orthopedics
Outcome results
None listed